TOWNSEND RICHARD NOLAN (Chief Executive Officer) received a stock award from LEXEO THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/17/2026ACC: 0001995218-26-000006
DirectorOfficer· Chief Executive Officer
Since Feb 2026
+2.62K
Net shares
Net buyer
$6.9K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
2.62K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+2.62K
Price / share
$2.64
Trade value
$6.94K
% of position
0.7%
3/13/2026
392.48K→395.11K
Total
Net shares
+2.62K
Net value
$6.94K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/13/2026 | A · Award | +2.62K | $2.64 | $6.94K | 0.7% | 392.48K | 395.11K |
| Total | +2.62K | $6.94K | ||||||
Derivative Transactions0
No derivative transactions reported